JMM Market Access Edition Features Editorial by Skila's Susan Dorfman & Pragmedic's Dr. Brian Smith

April 19, 2010 - PRLog -- Skila’s Dr. Susan Dorfman, Global Vice President of Marketing, Product Innovation and Alliances, and Dr. Brian D. Smith, founder of Pragmedic and editor of the Journal of Medical Marketing, have been featured at eyeforpharma’s Market Access Europe 2010 Conference in London, focusing on their editorial in the Journal of Medical Marketing’s special Market Access issue.

“Pricing, Market Access, and the Return of Reality” focuses on issues within the healthcare and Market Access industry, specifically the price mechanism.  This mechanism for health-care products is often distorted, making it difficult for healthcare professionals and healthcare administrators to work together to decide on the value of a product.  As a result, healthcare systems are not always receiving the value of what they are paying for.  Ultimately, the outcome is that less money is available to spend on superior products which will eventually benefit society less.  

“Market Access is probably the single most important issue facing marketers in pharmaceutical and medical technology today”, expresses Dr. Smith. “It is crucial to listen to experts explain where the frontiers of our knowledge and practice lie and where the next advances might arise.”

Critical factors for Market Access teams to be successful include the pricing of products, communicating value to payers, and integrating those activities with the rest of the discovery and development process.  The significance of these factors, are basis for Skila’s Market Access business solution, iAccess.

“Understanding the value of the investments a team has made in each account and communicating the value of your products is an essential part to determining an accurate pricing mechanism,” says Dorfman.  “Skila has designed iAccess with these needs specifically in mind. We understand how difficult this process can be without the right communication. However, with the right knowledge clients can adjust to the realities of a value-driven world.”

This editorial, which was presented by Dr. Smith during eyeforpharma’s Market Access Conference 2010 in London, further expresses the needs and concerns for pricing in today’s the market access industry.
About Skila
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in over 60 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients. To learn more about Skila, please visit our website at www.skila.com.

About PRAGMEDIC
PRAGMEDIC is a USA based healthcare software solutions provider. The company's stated goal is to facilitate the healthcare industry with its Simple, Effective, and Practical software solutions.

PRAGMEDIC platform is a comprehensive network of solutions comprising of vast range of software products and services designed to meet modern healthcare organizations’ information needs. Our combination of flexible, easy to use functionalities makes PRAGMEDIC the software solution of choice for a rapidly growing community of physicians, payers and consumers.

PRAGMEDIC’s information-centric architecture complements the unique needs of healthcare enterprises without disrupting existing workflows.

About Journal of Medical Marketing
Journal of Medical Marketing is the leading international journal for executives performing a marketing or commercial role at every company producing pharmaceuticals, medical devices or diagnostic equipment for the medical industry.
Every quarter, Journal of Medical Marketing publishes a wide range of peer-reviewed practice papers, research articles and professional briefings written by industry experts. Articles focus on the issues of key importance to medical marketers:
•   competitive strategies of leading players in the global market place
•   the impact of emerging market segments
•   alternative strategies for new market entry and existing market share defense
•   product strategies at all stages of the life cycle
•   the effectiveness of traditional and alternative channels of marketing communication
•   the implementation and control of full-mix marketing programs

# # #

Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, executive and alliance management teams.